<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677896/" ref="ordinalpos=2805&amp;ncbi_uid=4989294&amp;link_uid=PMC3677896" image-link="/pmc/articles/PMC3677896/figure/pone-0065032-g003/" class="imagepopup">Figure 3. Effects of SHH <span class="highlight" style="background-color:">signaling</span> antagonists on dying cell induced tumor cell repopulation..  From: Sonic Hedgehog <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> Supports Cancer Cell Growth during Cancer Radiotherapy. </a></div><br /><div class="p4l_captionBody">A. GDC0449, a preclinical SHH pathway inhibitor, inhibits Panc1Fluc cell growth induced by dying Panc1 cell in a dose-dependent manner. Top: signal intensity analysis from bioluminescence image; Bottom: representative bioluminescence images; scale bar represents 1 cm. *represents P&lt;0.05. B. Gant61 inhibits Panc1Fluc cells growth induced by dying Panc1 cells in a dose-dependent manner. Top: signal intensity analysis from bioluminescence image; Bottom: representative bioluminescence images; scale bar represents 1 cm. **represents P&lt;0.01. C. Cyclopamin inhibits HT29Fluc cell growth induced by dying HT29 cells in a dose-dependent manner. Top: signal intensity analysis from bioluminescence image; Bottom: representative bioluminescence images; scale bar represents 1 cm. *represents P&lt;0.05, **represents P&lt;0.01. D. Gant61 inhibits HT29Fluc cell growth induced by dying HT29 cells in a dose-dependent manner. Top: signal intensity analysis from bioluminescence image; Bottom: representative bioluminescence images; scale bar represents 1 cm. **represents P&lt;0.01. E. GDC0449 inhibits HT29 Fluc cell growth induced by dying HT29 cells in a dose-dependent manner. Top: signal intensity analysis from bioluminescence image; Bottom: representative bioluminescence images; scale bar represents 1 cm.</div></div>